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Ethnopharmacological  relevance:  Byrsonima  intermedia  A. Juss.  is  popularly  known  as  “murici  pequeno”  and
is  native  to the  Brazilian  Cerrado.  This  species  has  been  used  as an antimicrobial,  anti-hemorrhagic,  anti-
diarrheal and  anti-inﬂammatory.  Nevertheless,  scientiﬁc  information  regarding  Byrsonima  intermedia  is
limited;  there  are  no reports  related  to its possible  anti  inﬂammatory  and  antinociceptive  effects.  This
study  employed  in vivo  inﬂammatory  and  nociceptive  models  to  evaluate  the  scientiﬁc  basis  for  the
traditional  use  of Byrsonima  intermedia.
Materials  and  methods:  Carrageenan-induced  paw  edema,  peritonitis  and  ﬁbrovascular  tissue growth
induced  by s.c.  cotton  pellet  implantation  tests  were  used  to  investigate  the  anti-inﬂammatory  activity  of
Byrsonima  intermedia  aqueous  extract  (BiAE)  in  rats.  Mechanical  nociceptive  paw,  formalin  and  hot  plate
tests were  used  to  evaluate  the  antinociceptive  activity  in  mice.  High-performance  liquid chromatography
(HPLC),  phytochemistry  screening  and  determination  of total  phenolics  and  ﬂavonoids  were  used  to
determine  the  chemical  proﬁle  of  the  BiAE.
Results: BiAE  at  test  doses  of 30–300  mg/kg  p.o. clearly  demonstrated  anti-inﬂammatory  effects  by
reduced  carrageenan-induced  paw  edema,  by  inhibited  leukocyte  recruitment  into  the  peritoneal  cavity
and, in  the  model  of  chronic  inﬂammation,  by  using  the  cotton  pellet-induced  ﬁbrovascular  tissue  growth
in rats.  The  extracts  at test  doses  of  30–300  mg/kg  p.o.  clearly  demonstrated  antinociceptive  activity  in all
tests.  Administration  of  the opioid  receptor  antagonist  naloxone  completely  inhibited  the  antinociceptive
effect  induced  by BiAE  (100  mg/kg).
Conclusion:  BiAE  markedly  exhibits  anti-inﬂammatory  action  in  rats  and antinociceptive  activity  in  mice.
Thus,  it may  be useful  in  the  treatment  of  inﬂammatory  hyperalgesic  disorders,  which  supports  previous
claims  of its traditional  use.. Introduction
The genus Byrsonima belongs to the Malpighiaceae family of
owering plants, and it is widely distributed throughout tropical
merica (Felício et al., 1995). Byrsonima intermedia A. Juss. is pop-
larly known as “murici-pequeno” and is native to the Brazilian
errado (Anderson, 1979; Nogueira et al., 2007; Sannomiya et al.,
007; Agra et al., 2008).
This species has bark rich in tannins that are generally pheno-
ic secondary metabolites. These compounds have antimicrobial,
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anti-hemorrhagic, anti-diarrheal and anti-inﬂammatory activity
(Corrêa, 1984; Pinto and Bertolucci, 2002). Tea made from the
stem bark of small-murici has been popularly used in diarrhea and
dysentery as well as for antifungal and anti-inﬂammatory activity
(Rodrigues and Carvalho, 2001).
Chemical investigation of the methanol extract of Byrsonima
intermedia resulted in isolation of (+)-catechin, (−)-epicatechin,
quercetin-3-O--d-galactopyranoside, methyl gallate, gallic acid,
quercetin-3-O--l-arabinopyranoside, amentoﬂavone, quercetin,
quercetin-3-O-(2′′-O-galloyl)--galactopyranoside and quercetin-
3-O-(2′′-O-galloyl)--arabinopyranoside (Sannomiya et al., 2007).
Considering the use of Byrsonima intermedia in folk medicine
Open access under the Elsevier OA license. and the lack of scientiﬁc studies of its pharmacological properties,
the present study was  aimed at evaluating the anti-inﬂammatory
and analgesic effects of the stem bark extract from Byrsonima inter-
media in animal models.
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. Materials and methods
.1. Plant material
Stem bark from Byrsonima intermedia A. Juss. was  collected in
jaci, Minas Gerais, Brazil. The plant was identiﬁed by Dr. Renato
aiva from the Laboratory of Tissue Culture Plants of the Federal
niversity of Lavras (Lavras, Minas Gerais, Brazil), and the voucher
pecimen (17.601) has been deposited at the Herbarium of the Fed-
ral University of Lavras-MG.
.2. Preparation of the plant extracts and reference drugs
Stem bark from Byrsonima intermedia A. Juss. was dried in an
ven at 40 ◦C and powdered. The Byrsonima intermedia aqueous
xtract (BiAE) was obtained by decoction using 25 g of stem bark in
00 ml  of distilled water for 15 min  at a temperature of 100 ◦C. The
iAE was dried by lyophilization in the Liotop lyophilizer L-101.
The BiAE was  administered in 30, 100, and 300 mg/kg doses
fter being suspended in a vehicle (1% sodium carboxymethyl-
ellulose suspension in distilled water). To assess the possible
articipation of the opioidergic system in the Byrsonima intermedia
ntinociception, mice were pre-treated with the non-selective opi-
id receptor antagonist naloxone (0.4 mg/kg), which was injected
5 min  before the administration of the BiAE (100 mg/kg; p.o.)
nd morphine and tested using the hot plate test. The animals
n the control group received the same experimental handling as
hose in the test groups, with the exception of the drug treatment
eing replaced with appropriate volumes of the dosing vehi-
le. Dexamethasone (0.1 mg/kg), indomethacin (10 mg/kg), and
orphine sulfate (1 mg/kg or 10 mg/kg) were used as reference
rugs. All test drugs were intraperitoneally administered except
or indomethacin, which was orally administered.
.3. Compositional analysis of BiAE by HPLC
High performance liquid chromatography (HPLC) analysis of
iAE was performed on Shimadzu LC-100 equipment using a C18
olumn Shimadzu CLC ODS (250–4.6 mm)  with a 5 m particle size.
he mobile phases consisted of eluent A (0.5 mM/l  aqueous acetic
cid) and eluent B (methanol/acetic acid 0.1%). The gradient (A:B)
tilized was the following: 0,01–30 min  (10:90) and 30–45 min
0:100) with a solvent ﬂow rate of 1.0 ml/min and observation at
72 nm.  Additionally, an injection volume of 20 l at a concentra-
ion of 1 mg/ml  was used. LC solution software was  used for data
ollection.
.4. Phytochemical screening of the aqueous extract
The screening of chemical constituents (anthraquinones, tan-
ins, alkaloids, saponins, steroids, triterpenes and ﬂavonoids)
as performed on the aqueous extracts using chemical methods,
ccording to the methodology suggested by Matos (1997).
.5. Determination of total phenolics in the BiAE
The total phenol content of BiAE was determined using the
olin–Ciocalteu technique (Singleton et al., 1999). Brieﬂy, to
.5 ml  of BiAE 24 mg/ml  was added 2.5 ml  of 10% (v/v) aqueous
olin–Ciocalteu reagent. After 1 min, 2 ml  of 4% (w/v) aqueous
a2CO3 was added. After 2 h of incubation at 25 ◦C, the absorbance
as measured at 750 nm and compared with a gallic acid cali-
ration curve. The total phenolics were determined as gallic acid
quivalents (mg  gallic acid/g extract), and the values are presented
s means of triplicate analyses.acology 137 (2011) 1469– 1476
2.6. Determination of the total ﬂavonoids in the BiAE
Total ﬂavonoid content was  determined following Kalia et al.
(2008). In a 10 ml  test tube, 0.5 ml of BiAE 24 mg/ml, 1.5 ml  of
ethanol, 0.1 ml  of 10% (w/v) AlCl3·6H2O and 0.1 ml  of 1 M potas-
sium acetate were combined and mixed, and the volume was  made
up to 5.0 ml  with H2O. After 30 min, the mixture was  measured at
425 nm.  The standard curve for total ﬂavonoids was made using a
quercetin standard solution (25–120 g/ml) using the same proce-
dure as above. The total ﬂavonoids were determined as quercetin
equivalents (mg  quercetin/g extract), and the values are presented
as means of triplicate analyses.
2.7. Pharmacological procedures
2.7.1. Animals
Adult male Wistar rats weighing 180–220 g and adult male
Swiss mice weighing 28–32 g were obtained from the Central Ani-
mal  Facility of the Federal University of Alfenas and housed under
controlled light (12:12 h light:dark cycle; lights on at 6:00 am)  and
temperature conditions (23 ± 1 ◦C) with access to water and food
ad libitum. The animals were allowed to habituate to the housing
facilities for at least one week before the experiments were started.
All experiments were conducted in accordance with the Declara-
tion of Helsinki on the welfare of experimental animals and with
the approval of the Ethics Committee of the Federal University of
Alfenas (232/2009).
2.8. Evaluation of anti-inﬂammatory activity in rats
Carrageenan-induced rat paw edema:  Pedal inﬂammation was
produced in the rats as previously described (Vinegar et al., 1969;
Vilela et al., 2010) following an overnight fast with free access to
water. Paw edema was  measured with a plethysmometer (Model
7140, Ugo Basile, Italy). The basal volume of the right hind paw
was determined prior to the administration of any drug. After
the basal paw volume was  measured, the animals were divided
into experimental treatment groups (n = 8 per group) such that the
mean basal paw volume of each group was similar. Vehicle, BiAE or
indomethacin was administered orally 1 h prior to the intraplantar
injection of 1 mg  carrageenan in 100 l. The paw volume was mea-
sured at 1–4 h after injection of the inﬂammatory stimulus. Results
are presented as the change of paw volume (ml) in relation to the
basal paw volume.
Peritonitis induced by lipopolysaccharide:  In order to assess the
possible effect of BiAE on leukocyte recruitment into the peritoneal
cavity, the animals (n = 8 per group) were orally pre-treated with
vehicle, BiAE or indomethacin. After 30 min, lipopolysaccharide
(LPS) from Escherichia coli serotype 026:B6 dissolved in pyrogen-
free sterile saline was administered at a dose of 500 g/kg i.p.  Four
hours after the injection of LPS, rats were killed with an inhalatory
overdose of halothane and the cells from the peritoneal cavities
were harvested by injecting 10 ml  of PBS containing 0.5% sodium
citrate. The abdomens were gently massaged, and the blood-free
cell suspension was carefully aspirated with a syringe. Abdominal
washings were placed into plastic tubes and total cell counts were
performed immediately in a Neubauer chamber (Cunha et al., 1989)
Granulomatous tissue growth induced by s.c. cotton pellet implan-
tation: The effect of BiAE on the chronic or proliferative phases
of inﬂammation was  assessed in the cotton pellet granuloma
rat model, as described by Swingle and Shideman (1972).  Rats
were anesthetized with tribromoethanol (250 mg/kg; i.p.), and
then an autoclave sterilized cotton pellet that weighed 40 mg
was implanted subcutaneously, one on each side of the abdomen,
through a small ventral incision in the abdomen of the animal. The
different groups of rats (n = 8 per group) were administered the
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Fig. 1. HPLC/UV chromatograms of the Byrsonima 
ehicle, BiAE or dexamethasone once daily for seven consecutive
ays from the day of cotton pellet insertion. On the 8th day, the
nimals were euthanized with halothane. Each implanted cotton
ellet was removed with the surrounding ﬁbrovascular tissue and
ried at 40 ◦C for 24 h. Afterward, the dry weight was  measured,
nd results were expressed as the difference between the initial
mplanted cotton pellet weight and ﬁnal dry mass of the cotton
ellet and ﬁbrovascular tissue.
.9. Evaluation of antinociceptive activity in mice
Mechanical nociceptive paw test: In a quiet room, mice were
laced in acrylic cages (12 cm ×10 cm ×17 cm high) with a wire
rid ﬂoor 15–30 min  before testing. The test consisted of evoking
 hind paw ﬂexion with a handheld force transducer (Electronic
nesthesiometer Insight Model EFF-302, Brazil) adapted with
 0.5 mm2 polypropylene tip. The investigator was  trained to
pply the polypropylene tip perpendicularly to the central area
f the hind paw with a gradual increase in pressure. During this
daptation period, the paws were poked 2–3 times. Before paw
timulation, the animals were quiet, without exploratory move-
ents or defecation and not resting on their paws. The stimulation
f the paw was repeated until the animal presented two  similar
easurements (Cunha et al., 2004). Vehicle, BiAE or indomethacin
as orally administered 1 h before the i.pl. (intraplantar) injec-
ion of carrageenan (100 g/paw) or prostaglandin E2 (PGE2;
0 ng/paw). The results are expressed by the delta ()  withdrawal
hreshold (in g) calculated by subtracting the zero-time mean mea-
urements from the mean measurements at the indicated times
fter carrageenan or PGE2 (hypernociceptive agent) injection.
Formalin-induced nociception: A formalin solution (5% in 0.9%
aline; 20 l/paw) was injected into the hind paw plantar sur-
ace (i.p.), and the animals were individually placed in transparent
bservation chambers, as previously described (Santos and Calixto,
997; Vilela et al., 2009). Oral treatments (p.o.) with vehicle,.0 25.0 30.0 35.0 min
edia aqueous extract (BiAE) monitored at 272 nm.
indomethacin or BiAE were given 1 h prior to formalin injection
(n = 8 per group). Morphine (10 mg/kg, i.p.) was administrated
30 min  before the test. The time spent in licking the injected paw
was recorded and expressed as the total licking time in the early
phase (0–5 min) and late phase (20–30 min) after formalin injec-
tion.
Hot plate test: The hot plate was  an electrically heated sur-
face kept at a constant temperature of 50.0 ± 0.5 ◦C. Mice (n = 8 per
group) were placed on the heated surface within the Plexiglas walls
to constrain their locomotion on the plate. The latency to a discom-
fort reaction (licking of the paws or jumping) was  recorded at 0,
30, 60, and 120 min  after the administration of the vehicle, BiAE,
morphine (1 mg/kg), naloxone (0.4 mg/kg) plus BiAE (100 mg/kg;
p.o.) or naloxone (0.4 mg/kg) plus morphine (1 mg/kg), whereupon
the reaction time of 0 min  is the start of the test. A cut-off time of
20 s was  chosen to indicate complete analgesia and to avoid tissue
injury. The latencies for paw licking or jumping were recorded for
each animal (Yamamoto et al., 2002).
2.10. Open-ﬁeld test
In order to discard the possible nonspeciﬁc muscle relaxant or
sedative effects of the extract, the motor performance of the mice
was evaluated on the open-ﬁeld apparatus (Archer, 1973; Vilela
et al., 2009). Groups of mice (n = 8) received vehicle and BiAE (30,
100 and 300 mg/kg) 1 h before the test. Each animal was  placed in
the center of the open arena and allowed to have free ambulation
for 5 min  with observation of the locomotion frequency.
2.11. Evaluation of acute toxicity of the Byrsonima intermedia
extractBiAE (0.5–5 g/kg) was  orally administered to a group of mice,
both male and female. Behavior parameters observed after admin-
istration were convulsion, hyperactivity, sedation, grooming and
1472 L. Orlandi et al. / Journal of Ethnopharmacology 137 (2011) 1469– 1476
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Fig. 2. The effects of administration of the Byrsonima intermedia aqueous extract
(BiAE; 30, 100 and 300 mg/kg, p.o.) or indomethacin (10 mg/kg, p.o.) on rat paw
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Fig. 3. The effects of administration of the Byrsonima intermedia aqueous extract
(BiAE; 30, 100 and 300 mg/kg, p.o.) or indomethacin (INDO, 10 mg/kg, p.o.) on
lipopolysaccharide-induced recruitment of leukocytes into the peritoneal cavity
of  rats. Each column represents the mean ± S.E.M. of eight animals per group.
***p  < 0.001 compared with the saline + vehicle group. #p < 0.05, ##p < 0.01 and
68.7% inhibition (Fig. 4).
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esents the mean ± S.E.M. of eight animals. The asterisks denote the signiﬁcance
evels when compared with the vehicle group: ***p < 0.001.
ncreased or decreased respiration during a period of seven days.
ood and water were provided ad libitum.
.12. Statistical analysis
The data obtained were analysed using the GraphPad software
rogram Version 4.0 and expressed as mean ± S.E.M. Statistically
igniﬁcant differences between groups were calculated by the
pplication of an analysis of variance (ANOVA) followed by the
ewman–Keuls test. p-values less than 0.05 (p < 0.05) were con-
idered signiﬁcant.
. Results
.1. Extract yields, HPLC analysis, phytochemistry screening, total
henol and ﬂavonoid content
The yield from the Byrsonima intermedia aqueous extract was
6.0%. The phytochemical screening results of the aqueous extract
howed the presence of different types of active constituents such
s ﬂavonoids, triterpenes, steroids, tannins and saponins. Fig. 1
hows the HPLC analytical plot for Byrsonima intermedia at 272 nm,
ith the components as polar substances (retention time 2.92, 4.19,
.77, 5.97, 9.05, 9.29, 10.77, 12.13, 14.98 min). The amount of total
henolics in BiAE was determined by the Folin–Ciocalteu method.
he total phenolic content was expressed in gallic acid equivalents.
he results showed that the level of polyphenolics in BiAE was
7.3 mg/g extract. The content of total ﬂavonoids was 6.3 mg  as
uercetin equivalents/g extract.
.2. Evaluation of anti-inﬂammatory activity in rats
Carrageenan-induced rat paw edema:  Fig. 2 shows that
iAE signiﬁcantly inhibited carrageenan-induced rat paw edema
F4,33 = 7.34; p < 0.001). Four hours after the injection of car-
ageenan, the oral administration of 300 mg/kg BiAE reduced
F4,33 = 7.34; p = 0.0002; Fig. 2) the edematous response by 49%. The
eduction in inﬂammation by BiAE was comparable to a 10 mg/kg
ose of indomethacin, which reduced edema inﬂammation by
2.3%
Peritonitis induced by lipopolysaccharide:  In agreement with pre-
ious studies, LPS-induced peritonitis was followed by a signiﬁcant###p < 0.001 compared with LPS + vehicle group.
increase in the number of leukocytes in the peritoneal cavity of rats
when compared with the control group treated only with vehicle
(Cunha et al., 1989). Fig. 3 shows that BiAE signiﬁcantly inhibited
leukocyte recruitment into the peritoneal cavity in rats (F5,35 = 7.35;
p < 0.001). The inhibitory values of leukocyte recruitment at 4 h
post-LPS were 36.4%, 54.9% and 68.2% for 30, 100 and 300 mg/kg
of the extract, respectively. Indomethacin (10 mg/kg) gave a per-
centage inhibition of 67.7%.
Granulomatous tissue growth induced by s.c. cotton pellet
implantation: In the model of chronic inﬂammation using cot-
ton pellet-induced ﬁbrovascular tissue growth in rats, BiAE
signiﬁcantly inhibited (F4,35 = 12.20; p < 0.001) the formation of
granulation tissues. In this model, 30, 100 and 300 mg/kg of
extract produced 37.2%, 32.9% and 41.2% inhibition of the gran-
uloma weight, respectively, whereas dexamethasone producedFig. 4. The effects of administration of the Byrsonima intermedia aqueous extract
(BiAE; 30, 100 and 300 mg/kg, p.o.) or dexamethasone (DEXA; 0.1 mg/kg p.o.) on
the  formation of granulomatous tissue. Each bar represents the mean ± S.E.M. of
eight  animals. The asterisks denote the signiﬁcance levels when compared with the
control group: **p < 0.01; ***p < 0.001.
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Fig. 6. The effects of oral administration of the Byrsonima intermedia aqueous extract
on  the licking induced by formalin in mice. The animals were pretreated orally
with vehicle, BiAE (doses 30, 100, and 300 mg/kg), indomethacin (INDO; 10 mg/kg)
or  morphine (MORP; 10 mg/kg) prior to formalin. The total time spent licking the
hindpaw was  measured in the ﬁrst (Panel A) and second (Panel B) phases after intra-ompared with the control group: ***p < 0.001.
.3. Evaluation of antinociceptive activity in mice
Mechanical nociceptive paw test: The hypernociception induced
y applying carrageenan (100 g/paw) or PGE2 (10 ng/paw) was
etected by electronic von Frey anesthesiometer (Cunha et al.,
005). The BiAE administrated at doses of 30, 100 and 300 mg/kg
aused a signiﬁcant decrease (F4,38 = 12.38; p < 0.001) in the 
ithdrawal threshold (g) as compared with the control animals
reated with carrageenan (Fig. 5A), but not change response to PGE2
Fig. 5B). The reference drug indomethacin signiﬁcantly decreased
he  withdrawal threshold (g).
Formalin-induced nociception: BiAE at doses of 100 and
00 mg/kg p.o., had signiﬁcant antinociceptive activity compared
ith the control in both the ﬁrst (F5,52 = 11.71; p < 0.001) and sec-
nd phase (F5,52 = 22.2; p < 0.001), already the dose of 30 mg/kg
nhibited only the late phase. The reference drug indomethacin
uppressed only the second phase of the formalin test, whereas
orphine inhibited both phases of the pain stimulus (Fig. 6).
Hot plate test: The BiAE administrated at doses of 30, 100 and00 mg/kg caused a signiﬁcant increase in the response latency
ime at 30 min  as compared with the control animals (F6,70 = 6.41;
 < 0.001; Fig. 7). As expected, administration of the vehicle did notplantar injection of formalin. Each column represents the mean with S.E.M. for eight
mice in each group. The asterisks denote the signiﬁcance levels when compared with
the  control group: ***p < 0.001.
induce any antinociceptive effect. The reference drug morphine sig-
niﬁcantly increased the latency time (p < 0.001; Fig. 7). Trying to
elucidate the mechanism by which BiAE induces antinociception,
animals were pre-treated with naloxone. Fig. 7 shows that naloxone
completely blocked (p < 0.05) the morphine antinociceptive effect.
Naloxone also blocked the antinociceptive activity of the BiAE at
100 mg/kg dose. Effect of naloxone against BiAE was comparable
with those obtained with naloxone against morphine on both spinal
and supra-spinal models of analgesia
3.4. Open-ﬁeld test
A major concern in experiments designed to evaluate the anal-
gesic action of new agents is whether pharmacological treatment
causes other behavioral alterations, such as altering motor coor-
dination or sedation, which could be misinterpreted as analgesia.
Treatment with BiAE at 30–300 mg/kg did not cause a reduction in
the numbers of crossings and rearings in the open-ﬁeld test when
compared with the control group (data not shown).
3.5. Acute toxicityBiAE at doses of 0.5–5 g/kg, p.o., given to mice had no affect on
their behavioral responses during the observation period of seven
days following administration. No mortality was observed in the
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n this study were safe.
. Discussion
The treatment of various diseases with traditional medicine is
ecoming more popular. Many medicinal plants provide relief of
ymptoms comparable to that of conventional medicinal agents.
herefore, the present study was aimed at evaluating the scientiﬁc
asis for the traditional use of Byrsonima intermedia.
Oral treatment with the BiAE produced signiﬁcant inhibition of
arrageenan-induced paw edema comparable in magnitude with
he inhibitory action of indomethacin. This result suggests that the
nti-inﬂammatory actions of the extract are related to inhibition of
ne or more intracellular signaling pathways involved in the release
f the mediators mentioned above. In addition, BiAE signiﬁcantly
educed leukocyte migration to the peritoneal cavity, showing that
his extract probably contains active anti-inﬂammatory agents.
urthermore, BiAE decreased the wet and dry weight of the cotton
ellets compared with control groups. This reduction in inﬂamma-
ory granuloma tissue may  be due to both the ability of Byrsonima
ntermedia to reduce the number of ﬁbroblasts and the synthesis
f collagen and mucopolysaccharides, which are natural prolifera-
ive agents involved in the formation of granuloma tissue (Arrigoni,
977; Gupta et al., 2006).
It was previously demonstrated under the experimental con-
itions used in the present study that carrageenan induces
echanical hypernociception by activating a sequential cytokine
ascade released by the resident and migratory cells (Cunha et al.,
005; Verri et al., 2007). Following tissue injury and inﬂamma-
ion, nociceptors are sensitized in such a way that previously slight
r ineffective stimulation becomes painful. This decrease of noci-
eptive threshold response was denominated hypernociception
n experimental animals. The induction of inﬂammatory hyper-
ociception is primarily driven by the sensitization of primary
ociceptive neurons, an effect that is caused by nociceptor-
ensitizing mediators such as PGE2 (Möller et al., 1998; Vivancos
t al., 2004; Verri et al., 2007). Together with the produc-
ion of pro-nociceptive mediators during inﬂammation, evidence mg,  respectively) or naloxone + BiAE (NLX+ BiAE; 0.4 mg and 100 mg,  respectively)
e in each group. The symbols denote the signiﬁcance levels: *p < 0.05, **p  < 0.01;
ith the BiAE 100 mg/kg group; †p < 0.05 when compared with the morphine group.
indicates that there is a reduction of inﬂammatory hypernoci-
ception by antinociceptive and anti-inﬂammatory substances.
Based on the analgesic action of non-steroidal anti-inﬂammatory
drugs (NSAIDs), which inhibit the synthesis of prostaglandins,
it is currently accepted that these inﬂammatory mediators are
the main inducers of inﬂammatory pain (Ferreira et al., 1973).
Pre-treatment with the BiAE produced signiﬁcant inhibition of
intensity hypernociception comparable with the inhibitory action
of indomethacin. In our experimental model, BiAE was not able to
inhibit the PGE2-induced mechanical hypernociception. It is impor-
tant to mention that analgesics that act by inhibition of COX (NSAID)
or cytokine production (thalidomide) are not able to affect PGE2-
induced hypernociception (Ribeiro et al., 2000). This result suggests
that the antinociceptive actions of the extract are related to inhibi-
tion or reduction of chemical mediators of inﬂammation.
Intraplantar injection of formalin evokes a characteristic bipha-
sic licking response. The early phase corresponding to acute
neurogenic pain sensitive to drugs that interact with the opioid
system, starts immediately after injection and is considered likely
due to the direct stimulation of nociceptors, and the late phase cor-
responding to inﬂammatory pain responses, which is inhibited by
analgesic/anti-inﬂammatory drugs (Dubuisson and Dennis, 1977).
In this study, we can see that BiAE exerted inhibitory effects dur-
ing both phases of the formalin response. In the ﬁrst phase, BiAE
(100 or 300 mg/kg), used 60 min  before formalin injection, caused
a signiﬁcant antinociceptive activity compared with the control. It
has been suggested that the early phase is due to a direct effect
on nociceptors and that prostaglandins do not play a predominant
role during this phase. In the second phase, BiAE at every dose
caused signiﬁcant antinociceptive activity, thus suggesting central
and peripheral sites of extract action. It has been suggested that the
late phase seems to be an inﬂammatory response with inﬂamma-
tory pain that can be inhibited by anti-inﬂammatory drugs. These
data are in accordance with those of other authors who have shown
that drugs that act primarily as central analgesics inhibit both
phases, although peripherally acting drugs are not as good as cen-
tral analgesics, therefore inhibiting the late phase more (Hunskaar
and Hole, 1987).
The hot plate is a speciﬁc central antinociceptive test in which
opioid agents exert their analgesic effects via supra spinal and
spinal receptors. At constant temperature, two  kinds of behavioral
response, which are paw licking and jumping, both of these are con-
sidered to be supra spinally integrated responses (Chapman et al.,
1985; Nemirovsky et al., 2001) and considering the results of this
pharm
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tudy, the hot plate test was selected to be used to evaluate a pos-
ible central antinociception via supra spinal and spinal receptors
or the BiAE analgesic effect. In this study, the Byrsonima interme-
ia extract was found to have signiﬁcant antinociceptive activity
ompared with the control, which is a speciﬁc central antinocicep-
ive test. For the assessment of opioid system involvement in the
nalgesic activity the mice were pre-treated with an opioid antago-
ist naloxone. In this study, naloxone prevented the antinociceptive
ffect of BiAE in hot plate tests. These results suggest that at least
art of the anti-hyperalgesic effect observed for the extract is due to
he involvement of this system (-opioid) since naloxone reverted
he antinociceptive activity.
Our phytochemical screening demonstrated the presence of
avonoids, saponins, tannins, triterpenes and steroids. Flavonoids
nhibited the generation of superoxide anion and elastase released
y human neutrophils, indicating anti-inﬂammatory activity (Yen
t al., 2009). Compounds such as ﬂavonoids and triterpenes have
emonstrated anti-inﬂammatory activity, which may  explain the
ntinociceptive activity of BiAE (Beirith et al., 1999; Kim et al.,
004).
Several mechanisms of action could explain the pharmacolog-
cal activities found in the present study. Flavonoids, for example,
an stimulate NOS-2 via indirect inhibition of the COX and/or
ipoxygenase pathways and of the protein kinase C and/or l-
rginine/NO pathways (Robak et al., 1998; Meotti et al., 2006).
hese pathways have been implicated in a series of molecular
vents related to the nociceptive and inﬂammatory processes
Machelska et al., 1997; Kim et al., 2004). The ability of ﬂavonoids
nd triterpenes to inhibit the nuclear factor-kappa B (NF-B) could
larify the anti-inﬂammatory activity of the extract (Nam, 2006).
he antinociceptive activity of saponin has been associated with
he modulation of the GABAA, NMDA and non-NMDA receptors
t the supraspinal level. These authors have also reported that
he nonopioid-mediated saponin antinociception is modulated via
ctivation of the descending serotonin and 2-adrenergic path-
ays (Suh et al., 1996). However, additional studies are necessary
o establish the possible correlation between activities and chemi-
al composition of Byrsonima intermedia to ensure the appropriate
edicinal use of this plant.
In conclusion, the present study indicates that BiAE has both
nti-inﬂammatory and analgesic effects similar to those observed
ith indomethacin. The mechanism of action of BiAE might be asso-
iated with the inhibition or reduction of chemical mediators, such
s prostaglandin. Our study shows that BiAE has the potential to
e developed as a new product for the management of pain and
nﬂammation.
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